Company Analysis

Protagonist Therapeutics, Inc. (PTGX)

Nasdaq: PTGX · Pharmaceutical Preparations · Newark, CA · filing with the SEC since 2006
Grade5.7
◀ Past 4.3● Present 7.6▶ Future 4.9

Who runs Protagonist Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Patel Dinesh V Ph D
President and CEO. First filing Aug 2016, latest Sep 10, 2026, 23 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
23 people on the record since 2016
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Ali AsifChief Financial OfficerApr 2022Oct 2, 20267 · $15.6M
Patel Dinesh V Ph DPresident and CEOAug 2016Sep 10, 202614 · $60.6M
Molina Arturo MdChief Medical OfficerNov 2022Mar 27, 20266 · $4.5M
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Waddill William D.directorAug 2016Jun 25, 20266 · $5.6M
Giraudo BryandirectorMay 2017May 11, 20264 · $5.9M
Selick Harold EdirectorAug 2016Mar 27, 20261 · $2.5M
Williams Lewis TdirectorJun 2017Feb 18, 20261 · $1.5M
O'Dowd Sarah AdirectorAug 2020Jan 6, 2026none
Earlier names on the record26, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PTGX · research, not advice